# Initial Feasibility Study of the CycloPE® Device

> **NCT06970899** · NA · ACTIVE_NOT_RECRUITING · sponsor: **PATH EX, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Sepsis
- Infection
- Bacteremia Sepsis
- Systemic Inflammatory Response Syndrome (SIRS)

## Interventions

- **DEVICE:** PATH EX CycloPE® Device

## Key facts

- **NCT ID:** NCT06970899
- **Lead sponsor:** PATH EX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-11
- **Primary completion:** 2025-04-26
- **Final completion:** 2025-05-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06970899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06970899, "Initial Feasibility Study of the CycloPE® Device". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06970899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*